Deutsche Bank Ag\ Wave Life Sciences Ltd. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 70,466 shares of WVE stock, worth $761,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,466

Previous 44,710 57.61%

Holding current value

$761,737

Previous $366,000 137.98%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$8.0 - $16.44 $206,048 - $423,428	25,756 Added 57.61%	70,466 $871,000
Q3 2024 Nov 13, 2024	BUY	$5.12 - $9.01 $59,284 - $104,326	11,579 Added 34.95%	44,710 $366,000
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $21,518 - $31,836	4,913 Added 17.41%	33,131 $165,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $2,693 - $5,205	761 Added 2.77%	28,218 $174,000
Q4 2023 Feb 14, 2024	SELL	$4.16 - $6.87 $2,970 - $4,905	-714 Reduced 2.53%	27,457 $138,000
Q3 2023 Nov 09, 2023	SELL	$3.56 - $5.75 $854 - $1,380	-240 Reduced 0.84%	28,171 $161,000
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $99,722 - $133,247	28,411 New	28,411 $103,000
Q2 2022 Aug 11, 2022	SELL	$1.23 - $3.25 $30,913 - $81,682	-25,133 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.0 - $3.28 $5,716 - $9,374	-2,858 Reduced 10.21%	25,133 $50,000
Q4 2021 Feb 11, 2022	BUY	$3.14 - $5.15 $15,486 - $25,399	4,932 Added 21.39%	27,991 $87,000
Q3 2021 Nov 04, 2021	SELL	$4.89 - $7.12 $5,325 - $7,753	-1,089 Reduced 4.51%	23,059 $113,000
Q2 2021 Aug 11, 2021	BUY	$5.65 - $7.47 $11,605 - $15,343	2,054 Added 9.3%	24,148 $160,000
Q1 2021 May 13, 2021	SELL	$5.61 - $12.01 $11,236 - $24,056	-2,003 Reduced 8.31%	22,094 $123,000
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $81,594 - $108,091	-11,673 Reduced 32.63%	24,097 $190,000
Q3 2020 Nov 12, 2020	SELL	$8.49 - $19.54 $66,077 - $152,079	-7,783 Reduced 17.87%	35,770 $304,000
Q2 2020 Aug 13, 2020	SELL	$7.44 - $11.29 $54,713 - $83,026	-7,354 Reduced 14.45%	43,553 $453,000
Q1 2020 May 14, 2020	SELL	$6.94 - $14.22 $3,164 - $6,484	-456 Reduced 0.89%	50,907 $477,000
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $377,128 - $1.77 Million	-47,200 Reduced 47.89%	51,363 $411,000
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $1.04 Million - $1.49 Million	-54,328 Reduced 35.53%	98,563 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $1.59 Million - $2.98 Million	69,456 Added 83.25%	152,891 $3.99 Million
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $1.36 Million - $1.99 Million	41,640 Added 99.63%	83,435 $3.24 Million
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $1.03 Million - $1.39 Million	-27,830 Reduced 39.97%	41,795 $1.76 Million
Q3 2018 Dec 21, 2021	BUY	$36.35 - $55.2 $168,482 - $255,852	4,635 Added 7.13%	69,625 $3.48 Million
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $1.56 Million - $2.37 Million	-42,896 Reduced 39.76%	64,990 $3.25 Million
Q2 2018 Apr 21, 2020	BUY	$33.85 - $50.65 $211,156 - $315,954	6,238 Added 6.14%	107,886 $4.13 Million
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $1.25 Million - $1.87 Million	36,986 Added 57.2%	101,648 $3.89 Million
Q1 2018 Oct 18, 2019	BUY	$32.45 - $54.7 $120,032 - $202,335	3,699 Added 6.07%	64,662 $2.59 Million
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $1.13 Million - $1.9 Million	34,773 Added 132.77%	60,963 $2.44 Million
Q4 2017 Feb 14, 2018	SELL	$21.8 - $39.35 $267,202 - $482,312	-12,257 Reduced 31.88%	26,190 $918,000
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $630,530 - $963,097	38,447	38,447 $835,000

Others Institutions Holding WVE

# of Institutions

192

Shares Held

122M

Call Options Held

430K

Put Options Held

330K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $939M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account